DK1060749T3 - Vandigt farmaceutisk præparat indeholdende Tezosentan - Google Patents

Vandigt farmaceutisk præparat indeholdende Tezosentan

Info

Publication number: DK1060749T3
Authority: DK; Denmark
Prior art keywords: tezosentan; pharmaceutical preparation; preparation containing; aqueous pharmaceutical; aqueous
Prior art date: 1999-05-22

Application number

DK00110425T

Other languages

English (en)

Inventor

Peter Dr Actelion Pha Loeliger

Original Assignee

Actelion Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-22

Filing date

2000-05-16

Publication date

2003-06-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26070369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1060749(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-05-16 Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd

2003-06-23 Application granted granted Critical

2003-06-23 Publication of DK1060749T3 publication Critical patent/DK1060749T3/da

Links

TUYWTLTWNJOZNY-UHFFFAOYSA-N n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2h-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-propan-2-ylpyridine-2-sulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2C=C(N=CC=2)C2=NNN=N2)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)C)C=N1 TUYWTLTWNJOZNY-UHFFFAOYSA-N 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
229950000584 tezosentan Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

DK00110425T 1999-05-22 2000-05-16 Vandigt farmaceutisk præparat indeholdende Tezosentan DK1060749T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP9903532		1999-05-22
US09/573,504 US6316453B1 (en)	1999-05-22	2000-05-18	Aqueous pharmaceutical composition

Publications (1)

Publication Number	Publication Date
DK1060749T3 true DK1060749T3 (da)	2003-06-23

Family

ID=26070369

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00110425T DK1060749T3 (da)	1999-05-22	2000-05-16	Vandigt farmaceutisk præparat indeholdende Tezosentan

Country Status (12)

Country	Link
US (1)	US6316453B1 (da)
EP (1)	EP1060749B1 (da)
JP (1)	JP4632385B2 (da)
AR (1)	AR057123A1 (da)
AT (1)	ATE235255T1 (da)
CA (1)	CA2308660C (da)
DE (1)	DE60001768T2 (da)
DK (1)	DK1060749T3 (da)
ES (1)	ES2195818T3 (da)
NZ (1)	NZ504671A (da)
PT (1)	PT1060749E (da)
ZA (1)	ZA200002318B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7528065B2 (en) *	2006-01-17	2009-05-05	International Business Machines Corporation	Structure and method for MOSFET gate electrode landing pad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW313568B (da) *	1994-12-20	1997-08-21	Hoffmann La Roche
ES2221696T3 (es) *	1997-08-19	2005-01-01	F. Hoffmann-La Roche Ag	Procedimiento para la preparacion de piridinas 2,5.disustituidas.

2000
- 2000-05-11 ZA ZA200002318A patent/ZA200002318B/xx unknown
- 2000-05-16 PT PT00110425T patent/PT1060749E/pt unknown
- 2000-05-16 ES ES00110425T patent/ES2195818T3/es not_active Expired - Lifetime
- 2000-05-16 AT AT00110425T patent/ATE235255T1/de active
- 2000-05-16 DE DE60001768T patent/DE60001768T2/de not_active Expired - Lifetime
- 2000-05-16 DK DK00110425T patent/DK1060749T3/da active
- 2000-05-16 EP EP00110425A patent/EP1060749B1/en not_active Expired - Lifetime
- 2000-05-17 CA CA002308660A patent/CA2308660C/en not_active Expired - Fee Related
- 2000-05-18 US US09/573,504 patent/US6316453B1/en not_active Expired - Lifetime
- 2000-05-19 NZ NZ504671A patent/NZ504671A/en not_active IP Right Cessation
- 2000-05-19 JP JP2000148318A patent/JP4632385B2/ja not_active Expired - Fee Related
2006
- 2006-09-11 AR ARP060103943A patent/AR057123A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ504671A (en)	2001-11-30
PT1060749E (pt)	2003-08-29
ES2195818T3 (es)	2003-12-16
JP4632385B2 (ja)	2011-02-16
ATE235255T1 (de)	2003-04-15
DE60001768D1 (de)	2003-04-30
EP1060749B1 (en)	2003-03-26
US6316453B1 (en)	2001-11-13
CA2308660A1 (en)	2000-11-22
ZA200002318B (en)	2000-11-16
JP2001002564A (ja)	2001-01-09
AR057123A1 (es)	2007-11-14
CA2308660C (en)	2008-08-12
EP1060749A1 (en)	2000-12-20
DE60001768T2 (de)	2003-10-16

Publication	Publication Date	Title
NO20015175L (no)	2001-10-23	Farmasöytisk sammensetning
NO20071303L (no)	2001-07-27	Farmasoytiske preparater
EE200200097A (et)	2003-04-15	Bensamiididerivaati sisaldav farmatseutiline preparaat
EE05376B1 (et)	2011-02-15	Vesisuspensioonip?hineÁparenteraalneÁravimpreparaatÁjaÁsedaÁsisaldavÁviaal
FIU20000164U0 (fi)	2000-04-11	Uusi farmaseuttinen formulaatio
NO20020086D0 (no)	2002-01-08	Smaksmaskerte farmasöytiske flytende formuleringer
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
EE200200150A (et)	2003-04-15	Preparaat
NO20015670L (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
PT1210085E (pt)	2006-05-31	Solucoes farmaceuticas de levosimendano
NO20015149L (no)	2001-12-17	Nytt farmasöytisk preparat
NO20022606D0 (no)	2002-05-31	Farmasöytiske kombinasjoner
NO20014926L (no)	2001-12-13	Farmasöytiske forbindelser
NO20015148D0 (no)	2001-10-22	Nytt farmasöytisk preparat
EE200200073A (et)	2003-04-15	Bensamiididerivaati sisaldav farmatseutiline preparaat
DK1227817T3 (da)	2004-11-15	Ciclesonid-holdigt vandigt farmaceutisk præparat
ID30397A (id)	2001-11-29	Larutan oral prukaloprida
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
NO20015104L (no)	2001-12-19	Nytt farmasöytisk preparat
NO20016430D0 (no)	2001-12-28	Farmasöytisk kompleks
NO20015105L (no)	2001-12-19	Nytt farmasöytisk preparat
NO20032957L (no)	2003-08-28	Farmasöytisk emulsjonspreparat
NO20004816D0 (no)	2000-09-26	Ny farmasøytisk formulering
NO20021036L (no)	2002-04-26	Farmasöytisk preparat